Skip to main content
. 2021 Dec 6;12:765563. doi: 10.3389/fphar.2021.765563

TABLE 2.

Metabolic pathways of QRKSG during the treatment of NS.

NO Pathways Raw p -log(p) Impact Label
1 D-Glutamine and D-glutamate metabolism 2.30 × 10–3 2.64 0.5 a
2 Alanine, aspartate and glutamate metabolism 4.90 × 10–3 2.31 0.31 b
3 Arginine and proline metabolism 8.43 × 10–2 1.07 0.2 c
4 Arginine biosynthesis 6.12 × 10–4 3.21 0.18 d
5 Pentose phosphate pathway 3.13 × 10–2 1.5 0.09 e
6 Amino sugar and nucleotide sugar metabolism 3.85 × 10–1 0.41 0.05 f
7 Citrate cycle (TCA cycle) 2.30 × 10–1 0.64 0.03 g
8 Glutathione metabolism 4.90 × 10–3 2.31 0.03 h
9 Nitrogen metabolism 2.30 × 10–3 2.64 0 i
10 Butanoate metabolism 1.50 × 10–2 1.82 0 j